Cargando…

Effects of Atorvastatin on Negative Sign in Chronic Schizophrenia: a Double Blind Clinical Trial

The aim of this study was to evaluate the effects of Atorvastatin on negative symptoms in patients with chronic schizophrenia. The study was a prospective, double-blind, 6-week trial. Forty patients participated in the study; 19 patients were assigned to the Atorvastatin group as well as 21 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayyah, Mehdi, Boostani, Hatam, Ashrafpoori, Mitra, Pakseresht, Siroos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673957/ https://www.ncbi.nlm.nih.gov/pubmed/26664396

Ejemplares similares

Does atorvastatin have augmentative effects with sodium valproate in prevention of migraine with aura attacks? A triple-blind controlled clinical trial
por: Ganji, Reza, et al.
Publicado: (2021)

Evaluation of Pharmaceutical Products of St. John’s Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial
por: Pakseresht, Sirus, et al.
Publicado: (2012)

Detection of Borna Disease Virus (BDV) in Patients with First Episode of Schizophrenia
por: Soltani, Hasan, et al.
Publicado: (2016)

Evaluation of Atorvastatin for the Treatment of Patients With Asthma: A Double-Blind Randomized Clinical Trial
por: Moini, Abdollatif, et al.
Publicado: (2012)

Acetaminophen as Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Arabzadeh, Somaye, et al.
Publicado: (2018)

Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial
por: Mohammadi, Mehdi, et al.
Publicado: (2015)

Preventive Effect of Atorvastatin (80 mg) on Contrast-Induced Nephropathy After Angiography in High-Risk Patients: Double-Blind Randomized Clinical Trial
por: Khosravi, Arezoo, et al.
Publicado: (2016)

Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double‐blind, randomized, placebo‐controlled trial
por: Abdallah, Mahmoud S., et al.
Publicado: (2022)

Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial
por: Davoodi, Lotfollah, et al.
Publicado: (2021)

The Effectiveness of Group Cognitive Behavioral Therapy in Treating Obsessive-Compulsive Disorder in Women with Multiple Sclerosis (MS): A randomized double-blind controlled trial
por: Sayyah, Mehdi, et al.
Publicado: (2016)

The effect of intravenous Dexamethasone on post-cesarean section pain and vital signs: A double-blind randomized clinical trial
por: Shahraki, Azar Danesh, et al.
Publicado: (2013)

Evaluation of the Effect of Atorvastatin Administration on the Outcomes of Patients with Traumatic Brain Injury: A Double-blinded Randomized Clinical Trial
por: Soltani, Farhad, et al.
Publicado: (2021)

The effect of cognitive behavioral therapy on sexual function in reproductive aged women with hypothyroidism: a randomized controlled clinical trial
por: Sheikh Miri, Azam, et al.
Publicado: (2023)

A Double-Blind, Placebo-Controlled Study of the Aqueous Extract of Echium amoenum for Patients with General Anxiety Disorder
por: Sayyah, Mehdi, et al.
Publicado: (2012)

Effect of atorvastatin on iron metabolism regulation in patients with chronic kidney disease – a randomized double blind crossover study
por: Masajtis-Zagajewska, Anna, et al.
Publicado: (2018)

Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial
por: Kimer, Nina, et al.
Publicado: (2020)

Atorvastatin for preventing the progression of sepsis to severe sepsis (ASEPSIS Trial): a randomised, double-blind, placebo-controlled trial (ISRCTN64637517)
por: Patel, JM, et al.
Publicado: (2011)

Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)
por: Patel, Jaimin M, et al.
Publicado: (2012)

The effect of atorvastatin on inflammatory markers in sulfur mustard gas induced bronchitis: a randomized double-blinded, placebo-control clinical trial
por: Momeni, Behrooz, et al.
Publicado: (2021)

Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
por: Samaei, Areoo, et al.
Publicado: (2020)

Atorvastatin for unruptured intracranial vertebrobasilar dissecting aneurysm (ATREAT-VBD): protocol for a randomised, double-blind, blank-controlled trial
por: Turhon, Mirzat, et al.
Publicado: (2022)

The comparison of general health status between hemodialysis and kidney transplant patients in university hospitals of Ahvaz, Iran
por: Boostani, Hatam, et al.
Publicado: (2013)

Combination of atorvastatin/coenzyme Q10 as adjunctive treatment in congestive heart failure: A double-blind randomized placebo-controlled clinical trial
por: Pourmoghaddas, Masoud, et al.
Publicado: (2014)

Effects of vitamin D supplementation on depression and some selected pro-inflammatory biomarkers: a double-blind randomized clinical trial
por: Kaviani, Mina, et al.
Publicado: (2022)

Effects of High-Frequency rTMS on Negative Symptoms and Cognitive Function in Hospitalized Patients With Chronic Schizophrenia: A Double-Blind, Sham-Controlled Pilot Trial
por: Wen, Na, et al.
Publicado: (2021)

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
por: Rossell, Susan L., et al.
Publicado: (2016)

T51. TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH TRANSCRANIAL CURRENT STIMULATION (TDCS): RESULTS OF RANDOMIZED, DOUBLE-BLINDED, SHAM-CONTROLLED TRIAL
por: Valiengo, Leandro, et al.
Publicado: (2018)

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms
por: Neill, Erica, et al.
Publicado: (2022)

Efficacy of Atorvastatin in Prevention of Contrast-induced Nephropathy in High-risk Patients Undergoing Angiography: A Double-blind Randomized Controlled Trial
por: Syed, Maaz Hussain, et al.
Publicado: (2017)

Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial
por: Krivoy, Amir, et al.
Publicado: (2017)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010)

Atorvastatin for reduction of 28-day mortality in hospitalized COVID-19 patients: study protocol for a randomized, double-blinded, placebo-controlled, clinical trial
por: Emara, Moataz Maher, et al.
Publicado: (2022)

Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder
por: Hebrani, Paria, et al.
Publicado: (2015)

Effects of atorvastatin on plasma matrix metalloproteinase-9 concentration after glial tumor resection; a randomized, double blind, placebo controlled trial
por: Mohebbi, Niayesh, et al.
Publicado: (2014)

Comparison of the Efficacy of Atorvastatin and Rosuvastatin in Preventing Atrial Fibrillation after Coronary Artery Bypass Grafting: A Double-Blind Randomized Comparative Trial
por: Samadifar, Zahra, et al.
Publicado: (2023)

Effect of atorvastatin on subclinical atherosclerosis in virally-suppressed HIV-infected patients with CMV seropositivity: a randomized double-blind placebo-controlled trial
por: Yunihastuti, Evy, et al.
Publicado: (2023)

The Lipid lowering and Onset of Renal Disease (LORD) Trial: A randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease
por: Fassett, Robert G, et al.
Publicado: (2008)

Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial
por: Kimura, Genjiro, et al.
Publicado: (2016)

AN IMMUNOMODULATOR IN THE TREATMENT OF SCHIZOPHRENIA : A DOUBLE-BLIND STUDY
por: Agarwal, S., et al.
Publicado: (1992)

The Effects of Probiotics Supplementation on Clinical Status and Biomarkers of Oxidative Damage and Inflammation in Children with Brucellosis: A Randomized, Double-Blind, and Placebo-Controlled Trial
por: Zamani, Noushin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bnckd9ucjk4c6se6dm5br2j0pm